BioCryst Pharmaceuticals
BCRX
$4.16
Share price
0.00%
Change (1 day)
-45.34%
Change (1 year)
Categories
BioCryst Pharmaceuticals (BCRX) - Total assets
Total assets on the balance sheet as of December 2023 : $0.51 B
According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are $0.51 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $0.51 B | -6.01% |
| 2022-12-31 | $0.55 B | -6.49% |
| 2021-12-31 | $0.58 B | 75.72% |
| 2020-12-31 | $0.33 B | 90.96% |
| 2019-12-31 | $0.17 B | 19.37% |
| 2018-12-31 | $0.14 B | -17.62% |
| 2017-12-31 | $0.17 B | 98.4% |
| 2016-12-31 | $89.84 M | -26.57% |
| 2015-12-31 | $0.12 B | -10.6% |
| 2014-12-31 | $0.13 B | 180.1% |
| 2013-12-31 | $48.86 M | -14.93% |
| 2012-12-31 | $57.43 M | -30.13% |
| 2011-12-31 | $82.2 M | -24.89% |
| 2010-12-31 | $0.10 B | -23.03% |
| 2009-12-31 | $0.14 B | 67.89% |
| 2008-12-31 | $84.69 M | -40.66% |
| 2007-12-31 | $0.14 B | 108.39% |
| 2006-12-31 | $68.48 M | -31% |
| 2005-12-31 | $99.24 M | 205.68% |
| 2004-12-31 | $32.46 M | 7.88% |
| 2003-12-31 | $30.09 M | -27.13% |
| 2002-12-31 | $41.3 M | -30.11% |
| 2001-12-31 | $59.09 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $62.12 B | 11,917.37% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $75.11 B | 14,429.83% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | $3.26 B | 531.50% | 🇺🇸 USA |
 Repligen
RGEN | $2.82 B | 446.35% | 🇺🇸 USA |
 Novavax NVAX | $1.79 B | 247.70% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.46 B | -9.93% | 🇺🇸 USA |
 NanoViricides NNVC | $13.4 M | -97.41% | 🇺🇸 USA |
 Cel-Sci
CVM | $28.71 M | -94.45% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | $1.82 B | 252.68% | 🇺🇸 USA |